Pharmaceutical Supply – Antiviral Medication (Oseltamivir Phospha)

The Defense Logistics Agency, under the Department of Defense, has issued a subcontract for the supply of 44 precise packages of Oseltamivir Phosphate, commonly known as Tamiflu, to meet exact National Stock Number and National Drug Code specifications for medical procurement. This contract is part of a broader effort to ensure the availability of critical antiviral medication within military and defense healthcare systems, with all deliverables required to align strictly with federal pharmaceutical standards. The procurement is classified under NAICS code 325412, indicating it involves pharmaceutical and botanical product manufacturing, and is scheduled for performance with a posted date of July 15, 2026. The contract is non-competitive and not subject to set-aside provisions, emphasizing urgency and compliance over broad bidding. All items must be delivered to fulfill readiness requirements, though specific delivery locations and point of contact details are not disclosed in the available data. The official record can be referenced through the provided DIBBS link for full contractual terms and fulfillment details.